These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7359324)

  • 1. Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.
    Couvreur P; Kante B; Lenaerts V; Scailteur V; Roland M; Speiser P
    J Pharm Sci; 1980 Feb; 69(2):199-202. PubMed ID: 7359324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.
    Couvreur P; Kante B; Roland M; Speiser P
    J Pharm Sci; 1979 Dec; 68(12):1521-4. PubMed ID: 529043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
    Fontana G; Licciardi M; Mansueto S; Schillaci D; Giammona G
    Biomaterials; 2001 Nov; 22(21):2857-65. PubMed ID: 11561891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles in drug delivery.
    Douglas SJ; Davis SS; Illum L
    Crit Rev Ther Drug Carrier Syst; 1987; 3(3):233-61. PubMed ID: 3549008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides.
    Chavany C; Le Doan T; Couvreur P; Puisieux F; Hélène C
    Pharm Res; 1992 Apr; 9(4):441-9. PubMed ID: 1495887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles.
    Verdun C; Brasseur F; Vranckx H; Couvreur P; Roland M
    Cancer Chemother Pharmacol; 1990; 26(1):13-8. PubMed ID: 2322986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.
    Juliano RL; Stamp D
    Biochem Pharmacol; 1978 Jan; 27(1):21-7. PubMed ID: 619903
    [No Abstract]   [Full Text] [Related]  

  • 8. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.
    Fattal E; Vauthier C; Aynie I; Nakada Y; Lambert G; Malvy C; Couvreur P
    J Control Release; 1998 Apr; 53(1-3):137-43. PubMed ID: 9741921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polyalkylcyanoacrylate microspheres: a hepatic vector or a "furtive" vector].
    Couvreur P
    J Pharm Belg; 2000; 55(3):78-84. PubMed ID: 10925548
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation of tumor sensitivity in vitro. I. Comparative studies with the Jensen sarcoma in vivo and in vitro after 1-hour-incubation].
    Seidel HJ; Wegner LA
    Z Krebsforsch; 1969; 72(2):105-18. PubMed ID: 4182038
    [No Abstract]   [Full Text] [Related]  

  • 11. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.
    Brasseur F; Couvreur P; Kante B; Deckers-Passau L; Roland M; Deckers C; Speiser P
    Eur J Cancer (1965); 1980 Nov; 16(11):1441-5. PubMed ID: 7227421
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
    de Verdière AC; Dubernet C; Némati F; Soma E; Appel M; Ferté J; Bernard S; Puisieux F; Couvreur P
    Br J Cancer; 1997; 76(2):198-205. PubMed ID: 9231919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles of polyethylcyanoacrylates.
    Gonzalez-Martin G; Merino I; Rodriguez-Cabezas MN; Torres M; Nuñez R; Osuna A
    J Pharm Pharmacol; 1998 Jan; 50(1):29-35. PubMed ID: 9580223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interpretative analysis of the effect of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process.
    Vandelli MA; Fresta M; Puglisi G; Forni F
    J Microencapsul; 1994; 11(5):531-8. PubMed ID: 7815270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study of cytotoxic activity of vinblastine in a free form and associated with nanoparticles.
    Simeonova M; Antcheva M
    Acta Physiol Pharmacol Bulg; 1994; 20(2):31-5. PubMed ID: 7725930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanisms of binding of active drugs to polyalkylcyanoacrylate nanoparticles].
    Martin J; Macchi P; Hoffman M; Maincent P
    J Pharm Belg; 1994; 49(6):498-508. PubMed ID: 7884638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice.
    Nakada Y; Fattal E; Foulquier M; Couvreur P
    Pharm Res; 1996 Jan; 13(1):38-43. PubMed ID: 8668676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation.
    Fresta M; Puglisi G; Giammona G; Cavallaro G; Micali N; Furneri PM
    J Pharm Sci; 1995 Jul; 84(7):895-902. PubMed ID: 7562444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts.
    Illum L; Jones PD; Baldwin RW; Davis SS
    J Pharmacol Exp Ther; 1984 Sep; 230(3):733-6. PubMed ID: 6590835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entrapment of cisplatin into biodegradable polyalkylcyanoacrylate nanoparticles.
    Egea MA; Gamisans F; Valero J; Garcia ME; Garcia ML
    Farmaco; 1994 Mar; 49(3):211-7. PubMed ID: 7519014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.